1st Quarter - Report — THE PETRIZZO GROUP, INC. for CEL-SCI CORPORATION (2020)

Firm

THE PETRIZZO GROUP, INC.

Client

CEL-SCI CORPORATION

Income

$50,000

Expenses

—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Activity related to phase III clinical trial in head and neck cancer to boost the immune system before the ravages of surgery, radiation and chemotherapy. The Phase III trial is the largest ever in head and neck cancer with 928 patients enrolled.

Lobbyist	Covered position, as disclosed
TJ PETRIZZO	—

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Natl Institutes of Health (NIH); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.